AIM
ABMD

AIA Investment Management’s Abiomed Inc ABMD Stock Holding History

AIA Investment Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$1.62M Buy
5,833
+710
+14% +$205K 0.37% 58
2020
Q2 		$1.24M Sell
5,123
-143
-3% -$28.7K 0.28% 56
2020
Q1 		$764K Buy
5,266
+5,190
+6,829% +$862K 0.16% 53
2019
Q4 		$13K Buy
+76
New +$14.1K 0.02% 323

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AIA Investment Management's ABMD Position: Q3 2020 in Review

AIA Investment Management increased its Abiomed Inc (ABMD) stake by 14% in Q3 2020, buying an estimated $205K and bringing the position to 5,833 shares worth $1.62M. The position accounts for 0.37% of the portfolio, ranked #58.

AIA Investment Management first reported a position in ABMD in Q4 2019 and has held it in 4 quarters since. 498 funds tracked by Wall St. Rank hold ABMD as of Q3 2020.

  • AIA Investment Management held 5,833 shares of Abiomed Inc worth $1.62M as of Q3 2020.
  • AIA Investment Management bought 710 Abiomed Inc shares in Q3 2020, an estimated $205K.
  • Abiomed Inc made up 0.37% of AIA Investment Management's portfolio in Q3 2020, its #58 holding.
  • AIA Investment Management first reported a position in Abiomed Inc in Q4 2019 and has held it in 4 quarters since.
  • 498 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2020.

Based on AIA Investment Management's 13F filing for Q3 2020, filed 16 Nov 2020.